Huang A, Sun D, Koller A
Department of Physiology, New York Medical College, Valhalla 10595.
Hypertension. 1993 Dec;22(6):913-21. doi: 10.1161/01.hyp.22.6.913.
To elucidate the underlying reason or reasons for the increased peripheral resistance in hypertension, we investigated the pressure-diameter relation--the myogenic response--of isolated, cannulated arterioles (approximately 50 microns) of cremaster muscle of 12-week-old Wistar-Kyoto (WKY) rats, spontaneously hypertensive rats (SHR), and normal Wistar (NW) rats. All arterioles constricted in response to step increases in perfusion pressure from 20 to 160 mm Hg. This constriction was, however, significantly enhanced from 60 to 160 mm Hg in arterioles of SHR compared with NW or WKY rats. For example, at 80 and 140 mm Hg, respectively, the normalized diameter (expressed as a percentage of the corresponding passive diameter of arterioles of SHR) was 11.8% and 27.6% (P < .05) less compared with those of WKY rats. Endothelium removal eliminated the enhanced pressure-induced tone in SHR. Similarly, indomethacin (10(-5) mol/L, sufficient to block prostaglandin synthesis) or SQ 29,548 (10(-6) mol/L), a thromboxane A2-prostaglandin H2 receptor blocker that inhibited vasoconstriction to the thromboxane agonist U46619, attenuated the enhanced pressure-diameter curve and reversed the blunted dilation to arachidonic acid in SHR. In contrast, the thromboxane A2 synthesis inhibitor CGS 13,080 (5 x 10(-6) mol/L) did not affect the increased pressure-induced tone or the reduced dilation to arachidonic acid in SHR. Thus, the present findings suggest that in early hypertension pressure-induced arteriolar constriction is increased. This seems to be due to an enhanced production of endothelium-derived constrictor factors, primarily prostaglandin H2.
为了阐明高血压患者外周阻力增加的潜在原因,我们研究了12周龄的Wistar-Kyoto(WKY)大鼠、自发性高血压大鼠(SHR)和正常Wistar(NW)大鼠提睾肌中分离的、插管的小动脉(约50微米)的压力-直径关系——肌源性反应。随着灌注压力从20毫米汞柱逐步升高至160毫米汞柱,所有小动脉均出现收缩。然而,与NW或WKY大鼠相比,SHR小动脉在60至160毫米汞柱时的这种收缩明显增强。例如,在80毫米汞柱和140毫米汞柱时,与WKY大鼠相比,SHR小动脉的归一化直径(表示为SHR小动脉相应被动直径的百分比)分别减少了11.8%和27.6%(P <.05)。去除内皮消除了SHR中增强的压力诱导张力。同样,吲哚美辛(10^(-5)摩尔/升,足以阻断前列腺素合成)或SQ 29548(10^(-6)摩尔/升),一种血栓素A2-前列腺素H2受体阻滞剂,可抑制对血栓素激动剂U46619的血管收缩,减弱了增强的压力-直径曲线,并逆转了SHR中对花生四烯酸的扩张减弱。相比之下,血栓素A2合成抑制剂CGS 13080(5×10^(-6)摩尔/升)对SHR中增加的压力诱导张力或对花生四烯酸的扩张减少没有影响。因此,目前的研究结果表明,在早期高血压中,压力诱导的小动脉收缩增加。这似乎是由于内皮源性收缩因子,主要是前列腺素H2的产生增加所致。